- Global Pharma News & Resources

Press Releases - 2022-06-13

Date Title Company
13-Jun-2022 Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47 MorphoSys AG
13-Jun-2022 Global Silicone Elastomers Market (2022 to 2027) - Conductive Elastomers for Electrical Applications Presents Opportunities - Businesswire
13-Jun-2022 United States Industrial Ethernet Market Analysis Report 2022-2027 - Emergence of 5G to Create Lucrative Opportunities for Market Players - Businesswire
13-Jun-2022 Global Advanced Electronic Displays Markets Report 2022-2032 with Profiles of 275+ Companies - Businesswire
13-Jun-2022 Zapata Computing to Present at Quantum.Tech 2022 Businesswire
13-Jun-2022 Global Silicone Polymer Market Report to 2028 - by Type, End-use Industry and Region - Businesswire
13-Jun-2022 PharmaCyte Biotech to Attend 2022 BIO International Convention in San Diego Businesswire
13-Jun-2022 Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates Businesswire
13-Jun-2022 Asher Bio Appoints Andrea Pirzkall, M.D., as Chief Medical Officer Businesswire
13-Jun-2022 Stevanato Group Releases Sustainability Report 2021, Highlighting the Environmental, Social and Governance (ESG) Performance of the Group Businesswire
13-Jun-2022 Elektrofi Raises $40 Million Financing to Establish GMP Manufacturing Capabilities for Upcoming Clinical Studies and Expand Development Pipeline Businesswire
13-Jun-2022 ATCC Awarded Two Contracts from Gennova Biopharmaceuticals for the Continued Development of Cell Banks to Help Diagnose and Prevent Leishmaniasis Businesswire
13-Jun-2022 Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A Businesswire
13-Jun-2022 Cortexyme Appoints June Bray to its Board of Directors Businesswire
13-Jun-2022 Evecxia Therapeutics Announces Leadership Transition to Support Next Phase of Development and Growth Businesswire
13-Jun-2022 Global Neuroimmunology Drug Development Report 2022: Top 20 Neuroimmunology Products Forecast to be Worth $26.6 Billion by 2025 - Businesswire
13-Jun-2022 BeiGene Announces BRUKINSA™ (zanubrutinib) Is Approved in 50 Markets Businesswire
13-Jun-2022 ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer Businesswire
13-Jun-2022 Injectable Benzodiazepine Market to grow at 2.7% CAGR through 2030 MARKITWIRED
13-Jun-2022 Canine Atopic Dermatitis Treatment Market will surpass US$ 2.4 Billion in 2029 MARKITWIRED